Literature DB >> 28443951

Bariatric surgery in individuals with severe cognitive impairment: report of two cases.

Everton Cazzo1, Martinho Antonio Gestic2, Murillo Pimentel Utrini3, Felipe David Mendonça Chaim4, Elaine Cristina Cândido5, Luciana Bueno da Silveira Jarolavsky6, Ana Maria Neder de Almeida7, José Carlos Pareja8, Elinton Adami Chaim9.   

Abstract

CONTEXT: Bariatric surgery has become the gold-standard treatment for refractory morbid obesity. Obesity is frequently associated with certain syndromes that include coexisting cognitive deficits. However, the outcomes from bariatric surgery in this group of individuals remain incompletely determined. CASE REPORT: A 25-year-old male with Prader-Willi syndrome, whose intelligence quotient (IQ) was 54, was admitted with a body mass index (BMI) of 55 kg/m2, associated with glucose intolerance. He underwent the Scopinaro procedure for biliopancreatic diversion, with uneventful postoperative evolution, and presented a 55% loss of excess weight one year after the surgery, with resolution of glucose intolerance, and without any manifestation of protein-calorie malnutrition. A 28-year-old male with Down syndrome, whose IQ was 68, was admitted with BMI of 41.5 kg/m2, associated with hypertension. He underwent Roux-en-Y gastric bypass, with uneventful postoperative evolution. He presented a 90% loss of excess weight one year after the surgery, with resolution of the hypertension.
CONCLUSION: Bariatric surgery among individuals with intellectual impairment is a controversial topic. There is a tendency among these individuals to present significant weight loss and comorbidity control, but less than what is observed in the general obese population. The severity of the intellectual impairment may be taken into consideration in the decision-making process regarding the most appropriate surgical technique. Bariatric surgery is feasible and safe among these individuals, but further research is necessary to deepen these observations.

Entities:  

Mesh:

Year:  2017        PMID: 28443951     DOI: 10.1590/1516-3180.2016.0299071216

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  6 in total

1.  Factors Associated with Weight Loss After Metabolic Surgery in a Multiethnic Sample of 1012 Patients.

Authors:  Mario Masrur; Roberto Bustos; Lisa Sanchez-Johnsen; Luis Gonzalez-Ciccarelli; Alberto Mangano; Raquel Gonzalez-Heredia; Ronak Patel; Kirstie K Danielson; Antonio Gangemi; Enrique Fernando Elli
Journal:  Obes Surg       Date:  2020-03       Impact factor: 4.129

Review 2.  Bariatric Surgery in Children and Adolescents with Cognitive Impairment and/or Developmental Delay: Current Knowledge and Clinical Recommendations.

Authors:  Brittany E Matheson; Danielle Colborn; Cara Bohon
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

3.  Patients with Prader-Willi Syndrome (PWS) Underwent Bariatric Surgery Benefit more from High-Intensity Home Care.

Authors:  Songhao Hu; Biao Huang; Ken Loi; Xiaomei Chen; Qinyu Ding; Lan Luo; Cunchuan Wang; Wah Yang
Journal:  Obes Surg       Date:  2022-03-15       Impact factor: 3.479

Review 4.  Bariatric Surgery for Monogenic Non-syndromic and Syndromic Obesity Disorders.

Authors:  Niels Vos; Sabrina M Oussaada; Mellody I Cooiman; Lotte Kleinendorst; Kasper W Ter Horst; Eric J Hazebroek; Johannes A Romijn; Mireille J Serlie; Marcel M A M Mannens; Mieke M van Haelst
Journal:  Curr Diab Rep       Date:  2020-07-30       Impact factor: 4.810

Review 5.  Obesity management in Prader-Willi syndrome: current perspectives.

Authors:  Antonino Crinò; Danilo Fintini; Sarah Bocchini; Graziano Grugni
Journal:  Diabetes Metab Syndr Obes       Date:  2018-10-04       Impact factor: 3.168

6.  Health Problems in Individuals With PWS Are Associated With Lower Quality of Life for Their Parents: A Snapshot in the Brazilian Population.

Authors:  Alexandre Slowetzky Amaro; Daniela Andrea Rubin; Maria Cristina Triguero Veloz Teixeira; Arcenio José Ferreira; Graciele Massoli Rodrigues; Luiz Renato Rodrigues Carreiro
Journal:  Front Pediatr       Date:  2022-02-15       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.